Restenosis after endovascular PTA/stenting for supra-aortic branches in Takayasu aortitis: report of three cases and review of the literature

详细信息    查看全文

• 作者：Nobutaka Horie (1)
  Kentaro Hayashi (1)
  Minoru Morikawa (2)
  Gohei So (1)
  Hideaki Takahata (3)
  Kazuhiko Suyama (1)
  Izumi Nagata (1)
  
• 关键词：Takayasu aortitis ; PTA/stenting ; Restenosis
• 刊名：Acta Neurochirurgica
• 出版年：2011
• 出版时间：May 2011
• 年：2011
• 卷：153
• 期：5
• 页码：1135-1139
• 全文大小：326KB
• 参考文献：1. Bali HK, Jain S, Jain A, Sharma BK (1998) Stent supported angioplasty in Takayasu arteritis. Int J Cardiol 66(Suppl 1):S213鈥揝217 CrossRef
  2. Freeman JW, Snowhill PB, Nosher JL (2010) A link between stent radial forces and vascular wall remodeling: the discovery of an optimal stent radial force for minimal vessel restenosis. Connect Tissue Res 51:314鈥?26 CrossRef
  3. Giordano JM (2000) Surgical treatment of Takayasu鈥檚 arteritis. Int J Cardiol 75(Suppl 1):S123鈥揝128 CrossRef
  4. Hodgins GW, Dutton JW (1982) Subclavian and carotid angioplasties for Takayasu鈥檚 arteritis. J Can Assoc Radiol 33:205鈥?07
  5. Hotchi M (1992) Pathological studies on Takayasu arteritis. Heart Vessels Suppl 7:11鈥?7 CrossRef
  6. Johnston SL, Lock RJ, Gompels MM (2002) Takayasu arteritis: a review. J Clin Pathol 55:481鈥?86
  7. Kerr GS (1995) Takayasu鈥檚 arteritis. Rheum Dis Clin North Am 21:1041鈥?058
  8. Lee BB, Laredo J, Neville R, Villavicencio JL (2009) Endovascular management of Takayasu arteritis: is it a durable option? Vascular 17:138鈥?46
  9. Min PK, Park S, Jung JH, Ko YG, Choi D, Jang Y, Shim WH (2005) Endovascular therapy combined with immunosuppressive treatment for occlusive arterial disease in patients with Takayasu鈥檚 arteritis. J Endovasc Ther 12:28鈥?4 CrossRef
  10. Muller-Hulsbeck S, Schafer PJ, Charalambous N, Schaffner SR, Heller M, Jahnke T (2009) Comparison of carotid stents: an in-vitro experiment focusing on stent design. J Endovasc Ther 16:168鈥?77 CrossRef
  11. Numano F (2002) Takayasu鈥檚 arteritis: clinical aspects. In: Hoffman GS, Weyand CM (eds) Inflammatory diseases of blood vessels. Marcel Decker, New York, pp 455鈥?66
  12. Park MC, Lee SW, Park YB, Lee SK, Choi D, Shim WH (2006) Post-interventional immunosuppressive treatment and vascular restenosis in Takayasu鈥檚 arteritis. Rheumatology Oxford 45:600鈥?05 CrossRef
  13. Sharma BK, Jain S, Bali HK, Jain A, Kumari S (2000) A follow-up study of balloon angioplasty and de-novo stenting in Takayasu arteritis. Int J Cardiol 75(Suppl 1):S147鈥揝152 CrossRef
  14. Takahashi JC, Sakai N, Manaka H, Iihara K, Sakai H, Sakaida H, Higashi T, Ishibashi T, Nagata I (2002) Multiple supra-aortic stenting for Takayasu arteritis: extensive revascularization and two-year follow-up. AJNR Am J Neuroradiol 23:790鈥?93
  15. Tyagi S, Gupta MD, Singh P, Shrimal D, Girish MP (2008) Percutaneous revascularization of sole arch artery for severe cerebral ischemia resulting from Takayasu arteritis. J Vasc Interv Radiol 19:1699鈥?703 CrossRef
  
• 作者单位：Nobutaka Horie (1)
  Kentaro Hayashi (1)
  Minoru Morikawa (2)
  Gohei So (1)
  Hideaki Takahata (3)
  Kazuhiko Suyama (1)
  Izumi Nagata (1)
  
  1. Department of Neurosurgery, Nagasaki University School of Medicine, 1-7-1, Sakamoto, Nagasaki, 852-8501, Japan
  2. Department of Radiology, Nagasaki University School of Medicine, 1-7-1, Sakamoto, Nagasaki, 852-8501, Japan
  3. Department of Neurosurgery, Sasebo General Hospital, 9-3, Hirase, Sasebo, 857-8511, Japan
  

文摘

Recently, endovascular management has been reported as a feasible option for Takayasu aortitis. However, few papers have focused on restenosis in the follow-up, and therefore, it is important to predict high-risk cases for restenosis after endovascular treatment. We herein report three cases with Takayasu aortitis showing repeated restenosis after endovascular percutaneous transluminal angioplasty (PTA)/stenting and discuss its clinical implications with a review of the literature. We should keep in mind that endovascular PTA/stenting for Takayasu aortitis does not always keep the patency of the affected vessels, and severity of the stenosis and/or uncontrollable systemic inflammation could be a risk factor for restenosis. Therefore, careful follow-up under strict control of inflammation is mandatory. Overall, this method is effective as an initial treatment since repeated PTA is available until collateral supply develops.